Why is Fredun Pharma falling/rising?

As of 20-Oct, Fredun Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs. 1,640.00, reflecting a rise of Rs. 64.85 or 4.12%. The stock has recently hit a new 52-week and all-time high of Rs. 1,650, and it has outperformed its sector by 3.44%. Over the last three days, the stock has gained a total of 12.29%, and it opened today with a gap up of 4.68%. Despite this positive momentum, there has been a decline in investor participation, with delivery volume falling by 3.55% against the five-day average. Additionally, the stock is trading above its moving averages across various timeframes, indicating a strong upward trend.
In the broader market context, Fredun Pharmaceuticals has significantly outperformed the Sensex, with a one-week return of 9.22% compared to the benchmark's 2.47%. Over the past month, the stock has increased by 33.46%, while the Sensex has only risen by 2.10%. This substantial outperformance highlights the stock's strong momentum in contrast to the overall market. The liquidity of the stock remains adequate for trading, which supports its recent price movements. However, the falling investor participation could be a concern for future price stability.